In a patient with a history of iron‑deficiency anemia who now has normal hemoglobin and serum iron but an elevated red‑cell distribution width, low mean corpuscular hemoglobin, low mean corpuscular hemoglobin concentration, a negative celiac panel, and no heavy menstrual bleeding, is further workup indicated?

Further Workup for Persistent Red Cell Abnormalities After Iron Deficiency Anemia Treatment

Yes, further workup is indicated despite normal hemoglobin and iron levels, because the markedly elevated RDW (22%) and persistently low MCH (24) and MCHC (30) suggest either ongoing iron deficiency, a coexisting hemoglobinopathy (particularly thalassemia trait), or another underlying hematologic condition that requires identification.

Key Laboratory Findings Analysis

Your patient's current blood work reveals several concerning patterns:

• Elevated RDW (22%): This markedly elevated value indicates significant red cell size heterogeneity and is a sensitive early marker of iron deficiency that can persist even after hemoglobin normalization 1. An RDW >17.1 strongly suggests ongoing iron deficiency 2, and your patient's value of 22% is substantially higher than this threshold.

• Low MCH (24) and MCHC (30): These persistently low values indicate hypochromia and suggest either residual iron deficiency or a hemoglobinopathy 1. MCH is actually a more reliable marker of iron deficiency than MCV, as it is less dependent on storage conditions and counting machines 1.

Recommended Diagnostic Approach

Step 1: Reassess Iron Status with Appropriate Markers

Despite "normal" serum iron, you need comprehensive iron studies including:

• Serum ferritin: This is the single most powerful test for iron deficiency 1. A ferritin <30 μg/L indicates low body iron stores even without inflammation 1. Given the history of IDA, ferritin should ideally be >30 μg/L to confirm adequate repletion 1.

• Transferrin saturation: A value <16-20% suggests functional or absolute iron deficiency 1. This can reveal iron deficiency even when ferritin appears normal 1.

The combination of elevated RDW with low MCH/MCHC strongly suggests that iron stores may not be truly replete despite "normal" serum iron 1, 3.

Step 2: Rule Out Hemoglobinopathy

Hemoglobin electrophoresis is recommended to exclude thalassemia trait or other hemoglobinopathies, particularly given:

• Persistent microcytic/hypochromic indices despite treatment 1
• The pattern of low MCH and MCHC can occur in thalassemia trait, where MCV is typically reduced out of proportion to anemia 1
• This testing prevents unnecessary gastrointestinal investigation if a hemoglobinopathy is the underlying cause 1

Step 3: Consider Gastrointestinal Evaluation

If iron studies confirm ongoing deficiency and hemoglobin electrophoresis is normal, bidirectional endoscopy (upper endoscopy and colonoscopy) should be strongly considered 1:

• Blood loss from the GI tract is the most common cause of IDA in adults without menstrual bleeding 1
• Asymptomatic gastric and colonic malignancies can present with IDA 1
• Upper endoscopy should include small bowel biopsies even with negative celiac serology, as celiac disease can present with isolated iron deficiency 1
• Investigation should be considered at any level of anemia in the presence of iron deficiency 1

Step 4: Trial of Iron Supplementation as Diagnostic Test

A therapeutic trial of oral iron can serve as a diagnostic test 1:

• A hemoglobin rise ≥10 g/L within 2 weeks is highly suggestive of absolute iron deficiency, even if iron studies are equivocal 1
• This approach is particularly useful when ferritin levels are in the indeterminate range (30-100 μg/L) 1

Common Pitfalls to Avoid

• Don't assume "normal" serum iron equals adequate iron stores: Serum iron is a poor marker of total body iron status and fluctuates throughout the day 1, 4. Ferritin and transferrin saturation are far more reliable 1.

• Don't ignore persistent RBC abnormalities after hemoglobin normalization: The elevated RDW and low MCH/MCHC indicate that the underlying process causing the original anemia may still be active 1, 3, 5.

• Don't overlook dual pathology: Patients can have both iron deficiency and a hemoglobinopathy simultaneously 1, 6. The negative celiac panel doesn't exclude other causes of malabsorption or occult GI blood loss 1.

Clinical Algorithm Summary

1. Obtain comprehensive iron studies (ferritin, transferrin saturation, TIBC) 1
2. Order hemoglobin electrophoresis to exclude thalassemia trait 1
3. If iron deficiency confirmed: Consider GI evaluation (bidirectional endoscopy) given no obvious source of blood loss 1
4. If hemoglobinopathy identified: No further GI workup needed unless iron deficiency persists after adequate supplementation 1
5. Consider therapeutic trial of iron supplementation with reassessment in 2-4 weeks 1

The markedly elevated RDW of 22% is particularly concerning and should not be dismissed, as it represents the earliest morphologic change in iron deficiency and can indicate ongoing depletion even when hemoglobin appears normal 3, 5, 2.